Acorda Therapeutics Inc (NASDAQ:ACOR)

34.20
Delayed Data
As of Mar 27
 +1.26 / +3.83%
Today’s Change
28.26
Today|||52-Week Range
45.45
-16.32%
Year-to-Date
Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog
Mar 27 / Zacks.com
Sanofi Inks Multi-Component Strategic Deal with Evotec - Analyst Blog
Mar 20 / Zacks.com
Avalanche Biotechnologies (AAVL) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Mar 27 / Zacks.com
Inovio Pharmaceuticals, Inc. (INO) Jumps: Stock Rises 12.8% - Tale of the Tape
Mar 20 / Zacks.com
Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog
Mar 26 / Zacks.com
DBV Technologies (DBVT) Jumps: Stock Up 7.2% in Session - Tale of the Tape
Mar 19 / Zacks.com
Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog
Mar 26 / Zacks.com
AstraZeneca Presents Encouraging Heart Drug Brilinta Data - Analyst Blog
Mar 18 / Zacks.com
The Zacks Analyst Blog Highlights: HSBC Holdings, Goldman Sachs, Acorda Therapeutics,...
Mar 25 / Zacks.com
Teva Sells Four Oncology Development Assets to Ignyta - Analyst Blog
Mar 18 / Zacks.com
OvaScience, Inc. (OVAS) in Focus: Stock Surges 12.2% - Tale of the Tape
Mar 25 / Zacks.com
Regeneron Hits a 52-Week High on Positive Praluent Data - Analyst Blog
Mar 18 / Zacks.com
Coronado Biosciences, Inc. (CNDO) in Focus: Stock Jumps 8.6% - Tale of the Tape
Mar 25 / Zacks.com
Will Acorda Therapeutics (ACOR) Crush Estimates at Its Next Earnings Report? - Tale o...
Mar 18 / Zacks.com
Weakness Seen in Five Prime Therapeutics (FPRX) Estimates: Should You Stay Away? - Ta...
Mar 25 / Zacks.com
Pharma Stock Outlook: Let's Make a Deal - Industry Outlook
Mar 17 / Zacks.com
Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - Analyst Blog
Mar 24 / Zacks.com
Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews
Mar 17 / Zacks.com
2 Stocks to Beat the Dollar's Volatile Run - Analyst Blog
Mar 24 / Zacks.com
Merck Reports Encouraging Data from Cardiovascular Study - Analyst Blog
Mar 17 / Zacks.com
Vascular Biogenics (VBLT) Jumps: Stock Moves 5.2% Higher - Tale of the Tape
Mar 24 / Zacks.com
Why You Shouldn't Bet Against Acorda Therapeutics (ACOR) Stock - Tale of the Tape
Mar 17 / Zacks.com
Biogen Gains on Positive Alzheimer's Drug Interim Results - Analyst Blog
Mar 23 / Zacks.com
Eleven Biotherapeutics (EBIO) Crumbles: Stock Falls by 5.6% - Tale of the Tape
Mar 17 / Zacks.com
Celgene Presents Efficacy, Safety Data on Otezla - Analyst Blog
Mar 23 / Zacks.com
TrovaGene (TROV) in Focus: Stock Adds 6.1% in Session - Tale of the Tape
Mar 17 / Zacks.com
Pfizer Reveals Detailed Xeljanz Data from Psoriasis Study - Analyst Blog
Mar 23 / Zacks.com
Regeneron/Sanofi's PCSK9 Drug Praluent Data Published - Analyst Blog
Mar 16 / Zacks.com
Aeterna Zentaris Inc. (AEZS) in Focus: Stock Jumps 5.3% - Tale of the Tape
Mar 23 / Zacks.com
Amgen Presents Encouraging PCSK9 Inhibitor Repatha Data - Analyst Blog
Mar 16 / Zacks.com
Amicus Therapeutics Slumps: FOLD Falls 6.8% in Session - Tale of the Tape
Mar 23 / Zacks.com
Merck's Sugammadex Faces Setback, FDA Delays Meeting - Analyst Blog
Mar 16 / Zacks.com
Dicerna Pharmaceuticals (DRNA) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Mar 23 / Zacks.com
Alnylam Announces Positive Data from Natural History Study - Analyst Blog
Mar 16 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account